Ginkgo Bioworks Hldgs Inc (DNA)

$9.21 +0.20 (2.22%)
Market Cap 520.47M
Revenue (ttm) 227.04M
Net Income (ttm) -547.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -240.94%
Debt to Equity Ratio 0.00
Volume 949,800
Avg Vol 1,421,720
Day's Range N/A - N/A
Shares Out 60.59M
Stochastic %K 78%
Beta 1.54
Analysts Hold
Price Target $10.67

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, developm...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 422 5362
Address:
27 Drydock Avenue, 8th Floor, Boston, United States
AtomicAIerts
AtomicAIerts Dec. 5 at 11:02 AM
$DNA AtomicAlerts Scalp Alert Direction: LONG Entry: $9.23 TP1: $9.93 | TP2: $10.63 | TP3: $11.33 Stop Loss: $8.63 👉 https://atomicalerts.com
0 · Reply
Bbboston
Bbboston Dec. 5 at 6:04 AM
$DNA What’s the point of stating that you have loaded more puts without mentioning the strike and expiration date?
0 · Reply
Iightning
Iightning Dec. 5 at 6:00 AM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.50 Exit: 0.84 Return: +67.12% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 11:48 PM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.50 Exit: 0.84 Return: +67.12% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
HalfStacks
HalfStacks Dec. 4 at 8:30 PM
$DNA Loaded a few more calls, 12 EOW
1 · Reply
Yyzcan
Yyzcan Dec. 4 at 8:04 PM
$DNA just kindly remind that all the put had expired date, unless you deal with the air.
1 · Reply
Phantom_Shade_394
Phantom_Shade_394 Dec. 4 at 2:48 PM
$DNA If this platform ever processes just 30M of annual GMV from events and meals with a 10% take rate that’s 3M of revenue against a current 7M valuation, a simple 3x sales multiple already implies a 9M EV, 5x implies 15M, so I’m watching whether execution catches up to the optionality
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 4 at 11:52 AM
💎 LiquidTheta® Live Actionable Trade Asset: $DNA Contracts: $DNA January 15, 2027 $10 Calls Scale in: $2.92- $3.56 Scale out: $11.34-$19.44 Profit Potential : 420% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
papertrader_US
papertrader_US Dec. 4 at 11:41 AM
$DNA here's a reminder of the resident air trader. The infamous dude that "Short Every Pop"
1 · Reply
Iightning
Iightning Dec. 4 at 7:28 AM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.33 Exit: 0.56 Return: +71.09% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Latest News on DNA
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Dec 3, 2025, 8:00 AM EST - 1 day ago

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Nov 18, 2025, 8:00 AM EST - 16 days ago

Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

Ginkgo Bioworks: Not There Yet

Nov 11, 2025, 2:15 AM EST - 24 days ago

Ginkgo Bioworks: Not There Yet

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:26 PM EST - 4 weeks ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Earnings Call Transcript

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

Nov 3, 2025, 8:00 AM EST - 4 weeks ago

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

DCI

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Oct 31, 2025, 8:00 AM EDT - 4 weeks ago

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Oct 30, 2025, 4:05 PM EDT - 5 weeks ago

Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Oct 23, 2025, 8:00 AM EDT - 6 weeks ago

Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Sep 4, 2025, 8:00 AM EDT - 3 months ago

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Aug 29, 2025, 4:05 PM EDT - 3 months ago

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Aug 20, 2025, 8:01 AM EDT - 3 months ago

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Aug 12, 2025, 8:01 AM EDT - 4 months ago

Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth

Ginkgo Bioworks: Sell The Recent Rally

Aug 11, 2025, 5:51 AM EDT - 4 months ago

Ginkgo Bioworks: Sell The Recent Rally

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:16 AM EDT - 4 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 5:01 PM EDT - 4 months ago

Ginkgo Bioworks Reports Second Quarter 2025 Financial Results

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Jul 31, 2025, 8:01 AM EDT - 4 months ago

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Jul 30, 2025, 9:01 AM EDT - 4 months ago

Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Jul 17, 2025, 9:01 AM EDT - 5 months ago

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

May 21, 2025, 4:05 PM EDT - 7 months ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 8, 2025, 8:00 AM EDT - 7 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

TWST

Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:19 PM EDT - 7 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

May 6, 2025, 5:00 PM EDT - 7 months ago

Ginkgo Bioworks Reports First Quarter 2025 Financial Results

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Apr 30, 2025, 9:00 AM EDT - 7 months ago

Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Apr 29, 2025, 4:00 PM EDT - 7 months ago

Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Apr 22, 2025, 9:00 AM EDT - 8 months ago

Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Apr 10, 2025, 9:00 AM EDT - 8 months ago

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

DCI

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Apr 3, 2025, 9:01 AM EDT - 8 months ago

Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways

Ginkgo Bioworks: Revenue Struggles Continue

Feb 27, 2025, 10:29 AM EST - 10 months ago

Ginkgo Bioworks: Revenue Struggles Continue

2025 Is Make Or Break For Ginkgo Bioworks

Feb 27, 2025, 6:19 AM EST - 10 months ago

2025 Is Make Or Break For Ginkgo Bioworks

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Feb 26, 2025, 8:10 AM EST - 10 months ago

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLYW

Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 9:22 PM EST - 10 months ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 5:00 PM EST - 10 months ago

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Feb 21, 2025, 9:00 AM EST - 10 months ago

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Feb 20, 2025, 8:01 AM EST - 10 months ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Feb 18, 2025, 8:00 AM EST - 10 months ago

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Feb 6, 2025, 8:01 AM EST - 10 months ago

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

Jan 23, 2025, 8:01 AM EST - 11 months ago

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Jan 21, 2025, 7:00 AM EST - 11 months ago

SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Jan 13, 2025, 8:01 AM EST - 11 months ago

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Jan 9, 2025, 11:38 AM EST - 11 months ago

Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 8:00 AM EST - 11 months ago

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Dec 17, 2024, 8:11 AM EST - 1 year ago

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

Nov 18, 2024, 10:36 AM EST - 1 year ago

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

Ginkgo Bioworks: Not Enough Progress

Nov 13, 2024, 8:36 AM EST - 1 year ago

Ginkgo Bioworks: Not Enough Progress

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:02 PM EST - 1 year ago

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 5:01 PM EST - 1 year ago

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Nov 12, 2024, 8:01 AM EST - 1 year ago

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Nov 5, 2024, 7:00 AM EST - 1 year ago

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings

Oct 9, 2024, 3:39 PM EDT - 1 year ago

Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings

AtomicAIerts
AtomicAIerts Dec. 5 at 11:02 AM
$DNA AtomicAlerts Scalp Alert Direction: LONG Entry: $9.23 TP1: $9.93 | TP2: $10.63 | TP3: $11.33 Stop Loss: $8.63 👉 https://atomicalerts.com
0 · Reply
Bbboston
Bbboston Dec. 5 at 6:04 AM
$DNA What’s the point of stating that you have loaded more puts without mentioning the strike and expiration date?
0 · Reply
Iightning
Iightning Dec. 5 at 6:00 AM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.50 Exit: 0.84 Return: +67.12% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 11:48 PM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.50 Exit: 0.84 Return: +67.12% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
HalfStacks
HalfStacks Dec. 4 at 8:30 PM
$DNA Loaded a few more calls, 12 EOW
1 · Reply
Yyzcan
Yyzcan Dec. 4 at 8:04 PM
$DNA just kindly remind that all the put had expired date, unless you deal with the air.
1 · Reply
Phantom_Shade_394
Phantom_Shade_394 Dec. 4 at 2:48 PM
$DNA If this platform ever processes just 30M of annual GMV from events and meals with a 10% take rate that’s 3M of revenue against a current 7M valuation, a simple 3x sales multiple already implies a 9M EV, 5x implies 15M, so I’m watching whether execution catches up to the optionality
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 4 at 11:52 AM
💎 LiquidTheta® Live Actionable Trade Asset: $DNA Contracts: $DNA January 15, 2027 $10 Calls Scale in: $2.92- $3.56 Scale out: $11.34-$19.44 Profit Potential : 420% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
papertrader_US
papertrader_US Dec. 4 at 11:41 AM
$DNA here's a reminder of the resident air trader. The infamous dude that "Short Every Pop"
1 · Reply
Iightning
Iightning Dec. 4 at 7:28 AM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $10C Entry: 0.33 Exit: 0.56 Return: +71.09% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 6:55 AM
Hedge Alert Live - Protect Your Portfolio Contract: $DNA $9.00 Put · DEC 19, 2025 Exp Entry Price: $0.65 - $0.70 Exit Price Target: $1.31 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
TheHowlingMadness
TheHowlingMadness Dec. 4 at 12:17 AM
$DNA Sometimes folks heed healthy reminders.. Gl next er champ. Ill be here to collect 👊🤌
2 · Reply
Nalviation
Nalviation Dec. 3 at 10:56 PM
$DNA Can we please get other bears this guy really is boring 😴
3 · Reply
TheHowlingMadness
TheHowlingMadness Dec. 3 at 6:57 PM
$DNA loaded a few more puts here. 🤌
1 · Reply
austinmurphy05
austinmurphy05 Dec. 3 at 6:31 PM
$DNA Next NRG buyers stepped up on every dip since 1.10 the tape is telling you smart money is building a position before the real rerate begins 📈
0 · Reply
jaydilks
jaydilks Dec. 3 at 12:04 PM
$DNA Forgetting about the story, the Technical Analysis has a lot of PULL to the upside, slightly above today’s price. It just needs to get into the positive current, slightly above today’s price. It’s close. Past $9.19 is a bit of a tinderbox. That means GOOD.
1 · Reply
Iightning
Iightning Dec. 3 at 10:36 AM
1ightning® Premium Options Alert (Actionable) Ticker: $DNA Contract: Dec 19 $5C Entry: 7.70 Exit: 9.50 Return: +23.37% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
papertrader_US
papertrader_US Dec. 3 at 4:17 AM
$DNA it's business model is not to lose -53% in 6 weeks you dum dum. Weak!
1 · Reply
GoodTidings
GoodTidings Dec. 2 at 9:48 PM
$DNA This losses generator still active? Do they have any serious business model or is the business model burning through suckers investor money?!!! 🤔🤔🤔
0 · Reply
CallMeMyBeer
CallMeMyBeer Dec. 2 at 4:32 PM
$DNA 🤣🤣🤣🤣 bag holders stick together amirite? 🤣🤣🤣🤣
1 · Reply
jaydilks
jaydilks Dec. 2 at 12:04 PM
$DNA $BAYRY Bayer AG bought Monsanto in 2018 for $63 Billion and became inundated with Roundup lawsuits. Now it looks like Bayer might get some legal relief or at least the potential of it. In October 2022, Ginkgo bought Bayer’s R&D facility including IP for Microbial Strains. This was a big win for Ginkgo but the value of it has been decimated but not gone. It’s still there. With Accounting changes allowing full expensing of R&D, Ginkgo Bioworks is in a very good position to sell R&D services or be acquired by anyone for R&D. I have a funny feeling Bayer will be an active player either by partner or acquirer if they have cash available by not paying lawsuits. Nothing imminent but just a thought.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Dec. 2 at 8:56 AM
💎 LiquidTheta® Live Actionable Trade Asset: $DNA Contracts: $DNA January 15, 2027 $10 Calls Scale in: $2.87- $3.51 Scale out: $11.16-$19.14 Profit Potential : 444% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply